BioNTech SE
@BioNTech_Group
🔬 At #SABCS25, we shared interim global Phase 2 data from our investigational bispecific antibody program in metastatic #TNBC with our partner @bmsnews
Learn more in our press release: bit.ly/48CnnrC
#BreastCancerResearch #OncologyScience #BioNTech
Learn more in our press release: bit.ly/48CnnrC
#BreastCancerResearch #OncologyScience #BioNTech
0 20